| Dr Douglas Eli Cunningham, DPM | |
|
110 Doctors Dr, Suite B-1, Cheraw, SC 29520-7112 | |
| (843) 921-6711 | |
| (843) 921-6717 |
| Full Name | Dr Douglas Eli Cunningham |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 28 Years |
| Location | 110 Doctors Dr, Cheraw, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699761874 | NPI | - | NPPES |
| PD5220 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 522 (South Carolina) | Primary |
| 213ES0131X | Podiatrist - Foot Surgery | 522 (South Carolina) | Secondary |
| Provider Name | Caresouth Carolina Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1720082571 PECOS PAC ID: 1052221314 Enrollment ID: O20040511000280 |
News Archive
The incidence of spina bifida has decreased by 32 percent in the United States over the past decade. The decrease indicates the success of the Public Health Service's recommendations released in 1992 urging women to increase their levels of folic acid intake prior to becoming pregnant.
It will take at least 10 years to eradicate the H5N1 virus from poultry in the six countries where it is endemic, the U.N. Food and Agriculture Organization said in a report released on Thursday, Agence France-Presse reports.
A new gene therapy developed by researchers at the University of Missouri School of Medicine has been shown to protect mice from a life-threatening heart condition caused by muscular dystrophy.
Canyon PharmaceuticalsTM (www.canyonpharma.com) today announced the availability of Iprivask (desirudin for injection), the first direct thrombin inhibitor (DTI) approved in the United States by the Food and Drug Administration for the prevention of deep vein thrombosis (DVT), which may lead to pulmonary embolism in patients undergoing elective hip replacement surgery.
Results of preclinical studies by MUSC investigators reported in the July 2016 issue of PLOS One, demonstrate for the first time that the transcription factor KLF12 promotes CRC cell growth, in part, by activating EGR1. Furthermore, data demonstrate that KLF12 and EGR1 levels synergistically correlate with poor CRC prognoses.
› Verified 1 days ago
| Provider Name | Cheraw Foot Center Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1467571919 PECOS PAC ID: 1951413244 Enrollment ID: O20140228001266 |
News Archive
The incidence of spina bifida has decreased by 32 percent in the United States over the past decade. The decrease indicates the success of the Public Health Service's recommendations released in 1992 urging women to increase their levels of folic acid intake prior to becoming pregnant.
It will take at least 10 years to eradicate the H5N1 virus from poultry in the six countries where it is endemic, the U.N. Food and Agriculture Organization said in a report released on Thursday, Agence France-Presse reports.
A new gene therapy developed by researchers at the University of Missouri School of Medicine has been shown to protect mice from a life-threatening heart condition caused by muscular dystrophy.
Canyon PharmaceuticalsTM (www.canyonpharma.com) today announced the availability of Iprivask (desirudin for injection), the first direct thrombin inhibitor (DTI) approved in the United States by the Food and Drug Administration for the prevention of deep vein thrombosis (DVT), which may lead to pulmonary embolism in patients undergoing elective hip replacement surgery.
Results of preclinical studies by MUSC investigators reported in the July 2016 issue of PLOS One, demonstrate for the first time that the transcription factor KLF12 promotes CRC cell growth, in part, by activating EGR1. Furthermore, data demonstrate that KLF12 and EGR1 levels synergistically correlate with poor CRC prognoses.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Douglas Eli Cunningham, DPM 110 Doctors Dr, Suite B-1, Cheraw, SC 29520-7112 Ph: (843) 921-6711 | Dr Douglas Eli Cunningham, DPM 110 Doctors Dr, Suite B-1, Cheraw, SC 29520-7112 Ph: (843) 921-6711 |
News Archive
The incidence of spina bifida has decreased by 32 percent in the United States over the past decade. The decrease indicates the success of the Public Health Service's recommendations released in 1992 urging women to increase their levels of folic acid intake prior to becoming pregnant.
It will take at least 10 years to eradicate the H5N1 virus from poultry in the six countries where it is endemic, the U.N. Food and Agriculture Organization said in a report released on Thursday, Agence France-Presse reports.
A new gene therapy developed by researchers at the University of Missouri School of Medicine has been shown to protect mice from a life-threatening heart condition caused by muscular dystrophy.
Canyon PharmaceuticalsTM (www.canyonpharma.com) today announced the availability of Iprivask (desirudin for injection), the first direct thrombin inhibitor (DTI) approved in the United States by the Food and Drug Administration for the prevention of deep vein thrombosis (DVT), which may lead to pulmonary embolism in patients undergoing elective hip replacement surgery.
Results of preclinical studies by MUSC investigators reported in the July 2016 issue of PLOS One, demonstrate for the first time that the transcription factor KLF12 promotes CRC cell growth, in part, by activating EGR1. Furthermore, data demonstrate that KLF12 and EGR1 levels synergistically correlate with poor CRC prognoses.
› Verified 1 days ago
Cheraw Foot Center Pc Podiatrist Medicare: Medicare Enrolled Practice Location: 110 S Doctors Dr, Suite B1, Cheraw, SC 29520 Phone: 843-921-6711 Fax: 843-921-6717 | |
Caresouth Carolina, Inc Podiatrist Medicare: Medicare Enrolled Practice Location: 110 Doctors Dr Ste B1, Cheraw, SC 29520 Phone: 843-921-6711 |